mRNA |
thalidomide |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.8 |
mRNA |
Vorinostat |
FIMM |
pan-cancer |
AAC |
-0.042 |
0.8 |
mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.01 |
0.8 |
mRNA |
BMS-754807 |
FIMM |
pan-cancer |
AAC |
-0.035 |
0.8 |
mRNA |
THZ-2-49 |
GDSC1000 |
pan-cancer |
AAC |
-0.0087 |
0.8 |
mRNA |
Lisitinib |
GDSC1000 |
pan-cancer |
AAC |
-0.01 |
0.8 |
mRNA |
JQ-1:vorinostat (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0095 |
0.8 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.01 |
0.8 |
mRNA |
Sunitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.0098 |
0.8 |
mRNA |
PF-184 |
CTRPv2 |
pan-cancer |
AAC |
0.0093 |
0.8 |